

References
Armstrong MJ, Litvan I, Lang AE et al (2013) Criteria for the diagnosis of corticobasal degeneration. Neurology 80:496–503. doi:10.1212/WNL.0b013e31827f0fd1
Chien DT, Bahri S, Szardenings AK et al (2013) Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807. J Alzheimers Dis 34:457–468. doi:10.3233/JAD-122059
Dickson DW, Bergeron C, Chin SS et al (2002) Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol 61:935–946
Josephs KA, Whitwell JL, Ahmed Z et al (2008) Beta-amyloid burden is not associated with rates of brain atrophy. Ann Neurol 63:204–212. doi:10.1002/ana.21223
Josephs KA, Duffy JR, Strand EA et al (2012) Characterizing a neurodegenerative syndrome: primary progressive apraxia of speech. Brain 135:1522–1536. doi:10.1093/brain/aws032
Lowe VJ, Curran G, Fang P et al (2016) An autoradiographic evaluation of AV-1451 Tau PET in dementia. Acta Neuropathol Commun 4:58. doi:10.1186/s40478-016-0315-6
Marquie M, Normandin MD, Vanderburg CR et al (2015) Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue. Ann Neurol 78:787–800. doi:10.1002/ana.24517
Sander K, Lashley T, Gami P et al (2016) Characterization of tau positron emission tomography tracer [F]AV-1451 binding to postmortem tissue in Alzheimer’s disease, primary tauopathies, and other dementias. Alzheimers Dement. doi:10.1016/j.jalz.2016.01.003
Smith R, Puschmann A, Scholl M et al (2016) 18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers. Brain 139:2372–2379. doi:10.1093/brain/aww163
Acknowledgments
This study was supported by NIH Grants R01-NS89757 (PI, Josephs) and R01-DC12519 (PI, Whitwell).
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Josephs, K.A., Whitwell, J.L., Tacik, P. et al. [18F]AV-1451 tau-PET uptake does correlate with quantitatively measured 4R-tau burden in autopsy-confirmed corticobasal degeneration. Acta Neuropathol 132, 931–933 (2016). https://doi.org/10.1007/s00401-016-1618-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00401-016-1618-1
Keywords
Profiles
- Melissa E. Murray View author profile